
Evogene Ltd. EVGN
$ 1.11
-0.45%
Annual report 2024
added 01-03-2026
Evogene Ltd. EBITDA per Share 2011-2026 | EVGN
Annual EBITDA per Share Evogene Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -0.77 | -0.88 | -0.82 | -0.78 | -0.85 | -0.739 | -0.623 | -0.522 | -0.342 | -0.0701 | -0.101 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.0701 | -0.88 | -0.591 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
Aptorum Group Limited
APM
|
0.34 | $ 1.08 | 2.86 % | $ 5.89 M | ||
|
Adagene
ADAG
|
-0.63 | $ 1.67 | 9.14 % | $ 94 M | ||
|
Autolus Therapeutics plc
AUTL
|
-0.92 | $ 1.73 | -4.46 % | $ 441 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-1.68 | $ 3.56 | 1.14 % | $ 8.57 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
AstraZeneca PLC
AZN
|
0.74 | $ 94.01 | -0.68 % | $ 96.9 B | ||
|
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
Biogen
BIIB
|
4.62 | $ 184.91 | -1.44 % | $ 26.9 B | ||
|
BioNTech SE
BNTX
|
62.6 | $ 100.69 | 0.84 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
-8.25 | $ 199.49 | -1.72 % | $ 5 B | ||
|
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.01 | $ 4.16 | 0.48 % | $ 9.05 B | ||
|
Catalyst Biosciences
CBIO
|
-1 | $ 10.92 | 1.2 % | $ 719 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-0.11 | - | -15.15 % | $ 60.3 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
-1.85 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | ||
|
Celldex Therapeutics
CLDX
|
-2.98 K | $ 26.94 | -1.61 % | $ 1.73 M | ||
|
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-44.1 | - | 4.14 % | $ 49.1 M | ||
|
Cellectis S.A.
CLLS
|
-2.92 | $ 4.41 | - | $ 116 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
4.82 | $ 27.97 | 0.83 % | $ 1.35 B | ||
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | ||
|
Brickell Biotech
BBI
|
-1.17 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
1.11 | $ 9.4 | -0.53 % | $ 1.52 B | ||
|
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | ||
|
Arena Pharmaceuticals
ARNA
|
-10.2 | - | -6.81 % | $ 3.04 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
0.9 | $ 65.39 | 1.29 % | $ 8.75 B | ||
|
Athersys
ATHX
|
-0.382 | - | 3.77 % | $ 22.4 M | ||
|
Avenue Therapeutics
ATXI
|
-8.71 | - | -52.27 % | $ 4.45 M | ||
|
Abeona Therapeutics
ABEO
|
-2.1 | $ 5.12 | -1.35 % | $ 109 M | ||
|
AVROBIO
AVRO
|
0.24 | - | 1083.1 % | $ 745 M | ||
|
Axon Enterprise
AXON
|
1.41 | $ 627.91 | -0.6 % | $ 47.6 B | ||
|
ADiTx Therapeutics
ADTX
|
-2.07 K | $ 0.78 | -1.28 % | $ 10.3 K | ||
|
Aytu BioScience
AYTU
|
-0.39 | $ 2.68 | 1.52 % | $ 16.8 M | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
1.33 | $ 37.98 | 1.27 % | $ 3.92 B | ||
|
Завод ДИОД
DIOD
|
2.37 | - | - | - |